Mammalian model hosts of cryptococcal infection

Scott F Carroll1, Loïc Guillot, Salman T Qureshi

  • 1Department of Human Genetics, McGill University, Montreal, Canada.

Comparative Medicine
|March 14, 2007
PubMed

Insights

Serious fungal infections are increasing. This review explores mammalian models for studying Cryptococcus neoformans, an emerging fungal pathogen, aiding research into cryptococcosis and new treatments.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Serious fungal diseases, including those caused by Cryptococcus neoformans, pose a growing global health threat.
  • Cryptococcus neoformans is an emerging pathogen that can cause severe pneumonia and meningoencephalitis, particularly in immunocompromised individuals.
  • Recent advances in genomics are enhancing our understanding of C. neoformans biology and virulence.

Purpose of the Study:

  • To review and introduce various mammalian model hosts used for studying cryptococcosis.
  • To highlight the advantages, limitations, and potential of each model system for future research.
  • To emphasize the synergy between microbial genomics and well-characterized model hosts for advancing cryptococcal disease research.

Main Methods:

  • Review of existing literature on mammalian models for cryptococcosis research.
  • Analysis of the suitability of guinea pig, rabbit, rat, and mouse models.
  • Consideration of models amenable to immunologic and genetic manipulation.

Main Results:

  • Several mammalian models (guinea pig, rabbit, rat, mouse) are established for studying cryptococcosis.
  • Each model possesses unique advantages and limitations regarding disease manifestation and experimental manipulation.
  • Genomic data combined with model host studies offers a powerful approach to understanding pathogenesis.

Conclusions:

  • Mammalian models are crucial for advancing the study of Cryptococcus neoformans pathogenesis.
  • The selection of an appropriate model host is critical for effective research into cryptococcosis.
  • Future research integrating genomics and advanced model systems will accelerate the development of vaccines and antifungal therapies.